Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-agent: * Disallow: |
Title | Araris |
Description | Building tomorrow’s antibody-drug conjugates What we do Team Jobs News Contact Close Building tomorrow’s antibody-drug conjugates (ADCs) Araris Biotech AG , a spin-off company from the Paul Scherrer |
Keywords | N/A |
WebSite | ararisbiotech.com |
Host IP | 217.26.61.82 |
Location | Switzerland |
Site | Rank |
US$4,860,992
Last updated: 2023-05-11 07:07:09
ararisbiotech.com has Semrush global rank of 2,177,396. ararisbiotech.com has an estimated worth of US$ 4,860,992, based on its estimated Ads revenue. ararisbiotech.com receives approximately 560,884 unique visitors each day. Its web server is located in Switzerland, with IP address 217.26.61.82. According to SiteAdvisor, ararisbiotech.com is safe to visit. |
Purchase/Sale Value | US$4,860,992 |
Daily Ads Revenue | US$4,488 |
Monthly Ads Revenue | US$134,613 |
Yearly Ads Revenue | US$1,615,345 |
Daily Unique Visitors | 37,393 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
ararisbiotech.com. | A | 299 | IP: 217.26.61.82 |
ararisbiotech.com. | AAAA | 299 | IPV6: 2a00:d70:0:b:2002:0:d91a:3d52 |
ararisbiotech.com. | NS | 3600 | NS Record: ns3.hostpoint.ch. |
ararisbiotech.com. | NS | 3600 | NS Record: ns.hostpoint.ch. |
ararisbiotech.com. | NS | 3600 | NS Record: ns2.hostpoint.ch. |
ararisbiotech.com. | MX | 300 | MX Record: 10 mx01.sui-inter.net. |
ararisbiotech.com. | MX | 300 | MX Record: 10 mx02.sui-inter.net. |
ararisbiotech.com. | MX | 300 | MX Record: 10 mx03.sui-inter.net. |
ararisbiotech.com. | TXT | 300 | TXT Record: v=spf1 mx a include:_spf.sui-inter.net ~all |
What we do Team Jobs News Contact Close Building tomorrow’s antibody-drug conjugates (ADCs) Araris Biotech AG , a spin-off company from the Paul Scherrer Institute (PSI) and ETH Zurich, is pioneering the development of a novel, proprietary antibody-drug conjugate (ADC)-linker technology. Our linker platform enables payload attachment to ‘off-the-shelf’ antibodies in one step without needing to re-engineer or reduce antibodies, resulting in highly homogenous, stable and potent ADC therapies. Learn more — Intro to ADC — Araris Linker Technology News Araris Biotech AG Announces Strategic Investment with Samsung Ventures 12/04/23 Latest news: 05/05/23 — Araris Biotech AG supported with CHF 2.5M Swiss Accelerator Grant from Innosuisse to Develop Antibody-Drug Conjugate Candidates Stay in touch ...subscribe to our newsletter ADCs are powerful biopharmaceuticals, delivering highly toxic drugs, or payloads, specifically to cancer cells. ADCs consist of payloads connected to antibodies through |
HTTP/1.1 301 Moved Permanently Date: Thu, 04 Nov 2021 07:18:09 GMT Server: Apache Location: https://ararisbiotech.com/ Content-Type: text/html; charset=iso-8859-1 HTTP/2 301 location: https://www.ararisbiotech.com/ content-type: text/html; charset=iso-8859-1 date: Thu, 04 Nov 2021 07:18:09 GMT server: Apache HTTP/2 200 set-cookie: PHPSESSID=n6qqsk1sk47jmanihlhhaeq01bd85jn4; path=/ expires: Thu, 19 Nov 1981 08:52:00 GMT cache-control: no-store, no-cache, must-revalidate pragma: no-cache vary: Accept-Encoding content-type: text/html; charset=UTF-8 date: Thu, 04 Nov 2021 07:18:10 GMT server: Apache |
Domain Name: ARARISBIOTECH.COM Registry Domain ID: 2163523766_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.ascio.com Registrar URL: http://www.ascio.com Updated Date: 2021-09-16T07:33:12Z Creation Date: 2017-09-15T22:03:15Z Registry Expiry Date: 2022-09-15T22:03:15Z Registrar: Ascio Technologies, Inc. Danmark - Filial af Ascio technologies, Inc. USA Registrar IANA ID: 106 Registrar Abuse Contact Email: abuse@ascio.com Registrar Abuse Contact Phone: +1.4165350123 Domain Status: ok https://icann.org/epp#ok Name Server: NS.HOSTPOINT.CH Name Server: NS2.HOSTPOINT.CH Name Server: NS3.HOSTPOINT.CH DNSSEC: unsigned >>> Last update of whois database: 2021-10-21T07:07:35Z <<< |